A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
OPC-41061 at 7.5 mg/day or placebo will be orally administered once daily for 7 days to
cirrhosis patients with ascites despite having received treatment with conventional diuretics
and the change in body weight from baseline at the time of the final administration will be
compared between the two groups.